Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV

Conditions:   HPV Positive Oropharyngeal Squamous Cell Carcinoma;   HIV-1-infection;   HPV Infection Interventions:   Biological: 9 valent human papillomavirus vaccine (Types 6, 11, 16, 18, 31, 33, 45, 52, 58);   Other: Saline Placebo Sponsors:   Weill Medical College of Cornell University;   H. Lee Moffitt Cancer Center and Research Institute;   University of Sao Paulo;   University of Puerto Rico;   Mexican National Institute of Public Health;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials